Health care industry
Transnational Pharmaceutical Enterprises Shift Focus to R&D Investment in China
Transnational pharmaceutical enterprises have shown a significant shift in their investment strategies, prioritizing research and development (R&D) in China since the country's accession to the World Trade Organization (WTO) in 2002. Currently, the world's top 20 transnational pharmaceutical enterprises have established joint venture plants